Vext Science reports Q4 results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 31 2025
0mins
Source: SeekingAlpha
Financial Performance: Vext Science reported a Q4 2024 adjusted EBITDA of $3.2 million, significantly up from $0.5 million in Q4 2023, with revenue increasing by 21% year-over-year to $10.19 million.
Operational Improvement: The company achieved positive cash flow from operations in Q4 2024, totaling $4 million, compared to a negative cash flow of $0.7 million year-to-date at Q3 2024.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
